Pesquisa | Biblioteca Virtual em Saúde

1.

Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.

Rodrigues, Rebecca; Lai, Meng-Chuan; Beswick, Adam; Gorman, Daniel A; Anagnostou, Evdokia; Szatmari, Peter; Anderson, Kelly K; Ameis, Stephanie H.

J Child Psychol Psychiatry ; 62(6): 680-700, 2021 06.

Artigo em Inglês | MEDLINE | ID: mdl-32845025

2.

Implementation and evaluation of a curriculum on the assessment and treatment of disruptive behaviour disorders.

Doja, Asif; Pringsheim, Tamara; Andrade, Brendan F; Cowley, Lindsay; Healy, Sarah A; Baron, Tara; Chan, Melissa; DiBartolo, Marielena; Gripp, Karen; Manos, Sarah; Silverman, Jason A; Writer, Hilary; Gorman, Daniel A.

Paediatr Child Health ; 26(8): 458-461, 2021 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-34987676

3.

I Am Your Father.

Gorman, Daniel A.

JAMA ; 331(9): 731-732, 2024 03 05.

Artigo em Inglês | MEDLINE | ID: mdl-38335003

4.

Practitioner Review: On the trustworthiness of clinical practice guidelines - a systematic review of the quality of methods used to develop guidelines in child and youth mental health.

Bennett, Kathryn; Gorman, Daniel A; Duda, Stephanie; Brouwers, Melissa; Szatmari, Peter.

J Child Psychol Psychiatry ; 57(6): 662-73, 2016 06.

Artigo em Inglês | MEDLINE | ID: mdl-26945803

5.

The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.

Pringsheim, Tamara; Hirsch, Lauren; Gardner, David; Gorman, Daniel A.

Can J Psychiatry ; 60(2): 42-51, 2015 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-25886655

6.

The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers.

Pringsheim, Tamara; Hirsch, Lauren; Gardner, David; Gorman, Daniel A.

Can J Psychiatry ; 60(2): 52-61, 2015 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-25886656

7.

Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder.

Gorman, Daniel A; Gardner, David M; Murphy, Andrea L; Feldman, Mark; Bélanger, Stacey A; Steele, Margaret M; Boylan, Khrista; Cochrane-Brink, Kate; Goldade, Roxanne; Soper, Paul R; Ustina, Judy; Pringsheim, Tamara.

Can J Psychiatry ; 60(2): 62-76, 2015 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-25886657

8.

Uncovering the complexity of Tourette syndrome, little by little.

Gorman, Daniel A; Abi-Jaoude, Elia.

Br J Psychiatry ; 204(1): 6-8, 2014 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-24385458

9.

Assessment and Treatment of Oppositional Behaviour, Conduct Problems, and Aggression in Children and Adolescents: Creation and Dissemination of a National Curriculum.

Pringsheim, Tamara; Andrade, Brendan; Doja, Asif; Gorman, Daniel A.

Can J Psychiatry ; 62(6): 431-432, 2017 06.

Artigo em Inglês | MEDLINE | ID: mdl-28388224

10.

Case Report: Defining Applicant Attributes to Be Prioritized in the Selection of Child and Adolescent Psychiatry Subspecialty Residents at the University of Toronto.

Kulkarni, Chetana A; Rasasingham, Raj; Woods, Nicole N; Gorman, Daniel A; Szatmari, Peter; Hanson, Mark D.

Front Psychiatry ; 12: 650317, 2021.

Artigo em Inglês | MEDLINE | ID: mdl-33959054

11.

Psychosocial outcome and psychiatric comorbidity in older adolescents with Tourette syndrome: controlled study.

Gorman, Daniel A; Thompson, Nancy; Plessen, Kerstin J; Robertson, Mary M; Leckman, James F; Peterson, Bradley S.

Br J Psychiatry ; 197(1): 36-44, 2010 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-20592431

12.

Obsessive-compulsive disorder.

Gorman, Daniel A; Abi-Jaoude, Elia.

CMAJ ; 186(11): E435, 2014 Aug 05.

Artigo em Inglês | MEDLINE | ID: mdl-24664647

13.

Tourette syndrome.

Abi-Jaoude, Elia; Gorman, Daniel A.

CMAJ ; 185(3): 236, 2013 Feb 19.

Artigo em Inglês | MEDLINE | ID: mdl-23091179

14.

Managing attention-deficit/hyperactivity disorder.

Gorman, Daniel A; Abi-Jaoude, Elia.

CMAJ ; 185(15): E739, 2013 Oct 15.

Artigo em Inglês | MEDLINE | ID: mdl-23775617

15.

Deep brain stimulation for Gilles de la Tourette syndrome in children and youth: a meta-analysis with individual participant data.

Coulombe, Marie-Andrée; Elkaim, Lior M; Alotaibi, Naif M; Gorman, Daniel A; Weil, Alexander G; Fallah, Aria; Kalia, Suneil K; Lipsman, Nir; Lozano, Andres M; Ibrahim, George M.

J Neurosurg Pediatr ; 23(2): 236-246, 2018 10 26.

Artigo em Inglês | MEDLINE | ID: mdl-30497215

16.

Ferritin levels and their association with regional brain volumes in Tourette's syndrome.

Gorman, Daniel A; Zhu, Hongtu; Anderson, George M; Davies, Mark; Peterson, Bradley S.

Am J Psychiatry ; 163(7): 1264-72, 2006 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-16816233

17.

Increased number of subcortical hyperintensities on MRI in children and adolescents with Tourette's syndrome, obsessive-compulsive disorder, and attention deficit hyperactivity disorder.

Amat, Jose A; Bronen, Richard A; Saluja, Sanjay; Sato, Noriko; Zhu, Hongtu; Gorman, Daniel A; Royal, Jason; Peterson, Bradley S.

Am J Psychiatry ; 163(6): 1106-8, 2006 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-16741215

18.

The absence of a placebo group is a serious limitation of the STAR*D trial.

Gorman, Daniel A; Abi-Jaoude, Elia.

Can J Psychiatry ; 56(2): 126; author reply 126-7, 2011 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-21438419

19.

Disclosure: only a first step.

Abi-Jaoude, Elia; Gorman, Daniel A.

CMAJ ; 182(14): 1546, 2010 Oct 05.

Artigo em Inglês | MEDLINE | ID: mdl-20921261

20.

The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis.

Lam, Darren; Gorman, Daniel A; Patten, Scott; Pringsheim, Tamara.

Paediatr Drugs ; 15(4): 319-27, 2013 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-23529865

Biblioteca Virtual em Saúde

Saúde Pública Brasil

Sua seleção (0)

Formato de exportação:

Exportar:

Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.

Implementation and evaluation of a curriculum on the assessment and treatment of disruptive behaviour disorders.

I Am Your Father.

Practitioner Review: On the trustworthiness of clinical practice guidelines - a systematic review of the quality of methods used to develop guidelines in child and youth mental health.

Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder.

Uncovering the complexity of Tourette syndrome, little by little.

Assessment and Treatment of Oppositional Behaviour, Conduct Problems, and Aggression in Children and Adolescents: Creation and Dissemination of a National Curriculum.

Case Report: Defining Applicant Attributes to Be Prioritized in the Selection of Child and Adolescent Psychiatry Subspecialty Residents at the University of Toronto.

Psychosocial outcome and psychiatric comorbidity in older adolescents with Tourette syndrome: controlled study.

Obsessive-compulsive disorder.

Tourette syndrome.

Managing attention-deficit/hyperactivity disorder.

Deep brain stimulation for Gilles de la Tourette syndrome in children and youth: a meta-analysis with individual participant data.

Ferritin levels and their association with regional brain volumes in Tourette's syndrome.

Increased number of subcortical hyperintensities on MRI in children and adolescents with Tourette's syndrome, obsessive-compulsive disorder, and attention deficit hyperactivity disorder.

The absence of a placebo group is a serious limitation of the STAR*D trial.

Disclosure: only a first step.

The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis.